AKESF
Price
$14.50
Change
+$0.40 (+2.84%)
Updated
Nov 25 closing price
Capitalization
14.56B
Intraday BUY SELL Signals
INBX
Price
$84.12
Change
+$0.46 (+0.55%)
Updated
Nov 28 closing price
Capitalization
1.22B
Intraday BUY SELL Signals
Interact to see
Advertisement

AKESF vs INBX

Header iconAKESF vs INBX Comparison
Open Charts AKESF vs INBXBanner chart's image
AKESO
Price$14.50
Change+$0.40 (+2.84%)
Volume$639
Capitalization14.56B
Inhibrx Biosciences
Price$84.12
Change+$0.46 (+0.55%)
Volume$123.59K
Capitalization1.22B
AKESF vs INBX Comparison Chart in %
AKESF
Daily Signal:
Gain/Loss:
INBX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKESF vs. INBX commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and INBX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (AKESF: $14.50 vs. INBX: $84.12)
Brand notoriety: AKESF and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 59% vs. INBX: 28%
Market capitalization -- AKESF: $14.56B vs. INBX: $1.22B
AKESF [@Biotechnology] is valued at $14.56B. INBX’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than AKESF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 4 bullish TA indicator(s).

  • AKESF’s TA Score: 4 bullish, 3 bearish.
  • INBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AKESF is a better buy in the short-term than INBX.

Price Growth

AKESF (@Biotechnology) experienced а +3.57% price change this week, while INBX (@Biotechnology) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($14.6B) has a higher market cap than INBX($1.22B). AKESF has higher P/E ratio than INBX: AKESF (25.37) vs INBX (0.20). INBX YTD gains are higher at: 446.234 vs. AKESF (107.143).
AKESFINBXAKESF / INBX
Capitalization14.6B1.22B1,194%
EBITDAN/A-155.08M-
Gain YTD107.143446.23424%
P/E Ratio25.370.2012,812%
RevenueN/A1.4M-
Total CashN/A187M-
Total DebtN/A107M-
TECHNICAL ANALYSIS
Technical Analysis
AKESFINBX
RSI
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
75%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signal:
Gain/Loss:
INBX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CTOGX18.480.25
+1.37%
Calamos Timpani SMID Growth R6
CSSJX30.950.26
+0.85%
Carillon Chartwell Small Cap C
FILRX18.090.15
+0.84%
Franklin Intl Growth R6
MNDRX24.530.17
+0.70%
MFS New Discovery R2
FECMX48.600.02
+0.04%
Fidelity Advisor Emerging Markets I

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
N/A
INBX - AKESF
45%
Loosely correlated
+0.55%
SMMT - AKESF
27%
Poorly correlated
+0.39%
NUVL - AKESF
25%
Poorly correlated
+0.27%
BNTX - AKESF
23%
Poorly correlated
+0.44%
CPMV - AKESF
22%
Poorly correlated
+1.67%
More